Skip to main content

Table 1 Cytotoxicity (IC50) of compounds 1, 3–6, 7a–7e, 8a–e and doxorubicin as a standard against both MCF7, A549 cell lines

From: Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: synthesis, characterization, anticancer activity and antioxidant properties

Compound no.

MCF7 cell line

A459 cell line

IC50 ± SD (µM)

IC50 ± SD (µM)

1

1.857 ± 0.008

2.219 ± 0.002

3

0.562 ± 0.007

2.469 ± 0.006

4

3.074 ± 0.008

0.918 ± 0.002

5

0.924 ± 0.007

1.247 ± 0.002

6

0.329 ± 0.005

3.736 ± 0.002

7a

2.218 ± 0.004

1.586 ± 0.001

7b

0.474 ± 0.006

0.987 ± 0.002

7c

1.491 ± 0.004

0.496 ± 0.003

7d

0.495 ± 0.002

0.446 ± 0.004

7e

0.211 ± 0.002

0.155 ± 0.003

8a

0.872 ± 0.003

1.045 ± 0.006

8b

3.800 ± 0.008

0.527 ± 0.002

8c

0.215 ± 0.005

0.332 ± 0.002

8d

0.117 ± 0.004

0.515 ± 0.002

8e

0.461 ± 0.002

1.329 ± 0.004

Doxorubicin

0.053 ± 0.002

0.218 ± 0.005